J&J in ‘final stages’ of analyzing trial results for its one-dose COVID vaccine

by on

Johnson & Johnson last year enrolled 45,000 patients into a phase three clinical trial for its vaccine candidate. Those patients are still being monitored.

Johnson & Johnson last year enrolled 45,000 patients into a phase three clinical trial for its vaccine candidate. Those patients are still being monitored.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: